Síguenos en Twitter     Síguenos en Facebook     Síguenos en Google+     Síguenos en YouTube     Siguenos en Linkedin     Correo Grupsagessa     Gmail     Yahoo Mail     Dropbox     Instagram     Pinterest     Slack     Google Drive     Reddit     StumbleUpon     Print

SOBRE EL AUTOR **

Mi foto
FACP. Colegio de médicos de Tarragona Nº 4305520 / fgcapriles@gmail.com

WORLD EMERGENCY MEDICINE SOCIETIES

My Heart is Racing! Select Cardiac Arrhythmias and Practice Updates

Buscar en contenido

Contenido:

jueves, 12 de enero de 2017

Olanzapine IV

PulmCrit- January 11, 2017 - By Josh Farkas
"The potential role for IV olanzapine was examined in a post last year. The following conclusions were reached:
  • IV olanzapine appears to be safe.
  • IV olanzapine has equal potency compared to IV droperidol and about twice the potency of IV haloperidol.
  • Olanzapine doesn’t affect QT interval or cause torsade de pointes.
Two articles were just published in the Annals of Emergency Medicine about intravenous olanzapine. What does the new evidence show?
  • These studies validate the safety of IV olanzapine (now demonstrated in four studies including administration to 1,237 patients).
  • IV olanzapine has an efficacy equal to IV droperidol, and probably about twice as potent as IV haloperidol.
  • Addition of IV midazolam to IV droperidol hastens achievement of sedation, but this may come at the cost of increased respiratory suppression."